{"id":125093,"date":"2025-05-23T11:15:10","date_gmt":"2025-05-23T11:15:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/125093\/"},"modified":"2025-05-23T11:15:10","modified_gmt":"2025-05-23T11:15:10","slug":"mercaptopurine-tablets-recalled-over-contamination-fears","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/125093\/","title":{"rendered":"Mercaptopurine tablets recalled over contamination fears"},"content":{"rendered":"

Britons have been urged to check their pill drawer following an urgent medicine recall due to contamination fears.<\/p>\n

Aspen Pharma Trading Limited has issued a Class 2 Medicines Recall for a specific batch of Mercaptopurine 50mg tablets due to microbial contamination. <\/p>\n

The recall follows a small number of complaints about discoloured tablets discovered when packs were opened by healthcare professionals.<\/p>\n

The contamination has been identified as Penicillium Kongii, a type of fungus. The company is taking this action as a precautionary measure to ensure patient safety. <\/p>\n

\"PILLS<\/p>\n

Mercaptopurine is an active ingredient used in medical treatments<\/p>\n

GETTY<\/p>\n

Mercaptopurine is an active ingredient used in certain medical treatments, and authorities are advising both healthcare professionals and patients on appropriate next steps.<\/p>\n

The affected batch is identified as P0010384 with an expiry date of 31 December 2028. The 25-tablet packs were first distributed on 8 January 2025, just over four months ago.<\/p>\n

The issue came to light when healthcare professionals opened packs and noticed discoloured tablets. <\/p>\n

The product can be identified by its GTIN number 05060598250817 and is marketed under licence PL: 39699\/0047 by Aspen Pharma Trading Limited.<\/p>\n

Healthcare professionals have been instructed to immediately stop supplying the affected batch of Mercaptopurine tablets. <\/p>\n

They should quarantine all remaining stock and return it to their supplier using the supplier’s approved process.<\/p>\n

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued this guidance as part of the Class 2 recall procedure.<\/p>\n

For medical information enquiries about this product, healthcare professionals can email Aspenmedinfo@professionalinformation.co.uk or telephone 01748 828391.<\/p>\n

Those with stock control enquiries are advised to email uk.stockenquiries@aspenpharma.eu. <\/p>\n

NHS regional teams have been asked to forward this information to community pharmacists and dispensing general practitioners.<\/p>\n

\"Penicillium<\/p>\n

The contamination has been identified as Penicillium Kongii<\/p>\n

GETTY<\/p>\n

Patients are advised to check if they have received tablets from batch P0010384, with the batch number visible on the medicine bottle label.<\/p>\n

If tablets from this batch appear discoloured in any way, patients should contact their specialist or prescriber. <\/p>\n

“The tablets should be a \u2018pale yellow colour and are marked with \u2018PT \/ 50\u2019, as per the Patient Information Leaflet (PIL)” according to Gov.UK<\/p>\n

Importantly, patients should not stop taking their medication without discussing this with their healthcare professional, as additional monitoring may be required.<\/p>\n

Anyone experiencing adverse reactions or with questions about their medication should seek medical attention. <\/p>\n

Suspected adverse reactions should be reported via the MHRA Yellow Card scheme. The recall is being managed as a precautionary measure to ensure patient safety.<\/p>\n","protected":false},"excerpt":{"rendered":"Britons have been urged to check their pill drawer following an urgent medicine recall due to contamination fears.…\n","protected":false},"author":2,"featured_media":125094,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,388,4326,12,512,16,15],"class_list":{"0":"post-125093","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-lifestyle","10":"tag-medication","11":"tag-news","12":"tag-sgg","13":"tag-uk","14":"tag-united-kingdom"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/125093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=125093"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/125093\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/125094"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=125093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=125093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=125093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}